筑波大学技術報告
27: 8-13, 2007

ă¯kf 1ÿĴ]¾ 2łģhÃ 3Ĉå¡§dĻĔĄ§ćÌË©ň§Čŉ305-8575 Ġ#±¢ò 1-1-1

¬ ð*d!đĖ ~².öôçÂð !Û§ð 1đĖxi 0-ĐĚYMX¨ĸør. Brain Mapping Analyzer 1ĺü[1, 2]!ħė1÷ _ ì.
Í!ð !~²1Ï í¨ļýÒ.aù(!Îä1ĺü[3, 4]eVB
DĜ!] ,^ĆŅ!ð 1n ¨ĸ/,!~²1áĭ Òl1.


ĤuvûđĖ§Ôğä"ÈÈiÁ1÷đĖ_!Üý§ð !~²1 ĐÞĀ Ú}.Çä.=V3E6V=_z ®.Üý§ð(È)Ĥuð1ÜīÈi1ÁĤuń½Ĺ`Ĥu
ð !~²1į~Ò.)!.
Ăy"vûđĖ§Ôğ!Ĥu¸¶~²1¨ĸør. Brain Mapping Analyzer 1ĺü[1, 2]!ħė"ġ«Ĥuń½Ĺ!uJ[N\X1Êw -z!½¬Ń1ï« ,ü,/.Ĥu1ĳÉýí¨.  ., 1Įŀ=C\<1:[JU\A\»!`cÝsÎą xŁ1=7T[ ,Ĥu¸¶~²1~Ò.=C\<! ċ ´ (]¶ ¬ ð*d!Ĝxi1~Ò. ě.uÚ}ŇÄ¶!uŀ£oĉ1?BD -CYI5RV1÷ ør Òä*ŀâ§Ú}1÷ Ňİêi8ZOD9VK2\äá&­) 4Ög_½ĐÞĀ~ÒēÓ1º.  .
e Brain Mapping Analyzer 1÷ ]_Ŀ ì.Í!ð !~²1¨ĸ/,1ļýÒ.Îä1ĺü[3, 4]]l
E\HP[ (āĒhĲð !]) !Å1¹İàĽĪĊ.A3Z;[ãĶĵĎ (TH) !ĵĎçÂ1ĪĊ .5X;4QŊ5XS<U
W[m¦ÂLZC2[7F\@ II (CaMKII) $5
XS<UW[ (CaM) !VBDĜz!~²1 Ò
[3]t  CaM m¦Â!E\HP[ÅR5G>Q[5, 6]1đĖ§ý {Āĩ 1. ~ÒVBDĜŃĘ¤ĕ+-p%č 8.0 mm (A) $ 5.1 mm (B)!VBDĜ!|ñ1~Òb!ú¥"g`!į-.Ō a, pÕ; adt,µępÕ; AM, Æ×; arh, µ`Ĵ (·ñÕ);
avt, µĝpÕ; CAE,; CAI, z; CC,ĜØ; CI, °þ ; CM, ı þ ; CP, ĕÑi; CPF,Ùñþ ; CPS, ŋÝiÂÄþ ; DG, ßñ; FH,éņķ; GP, ëĢó; HI, éņ; mdt, µęzpÕ; pvh, µ`Ĵ (©qÕ); sl,
pbľÕ; sm, zpbľÕ; smt, µzp`Õ; TD, ª³; TO,ď; TOL,pď; TUO, ēĊ; vmh, µ`Ĵ(ĝzpÕ)

2.1 Ĝ!¨$jĨ¨ĸývûđĖ§ÜÐ1jĨ. "đĖ1ĐĴ'] ¨.À .¿Ğ ,¨ê1æwĥĉČ1įxĬ ¨ê1¼õİ*îè¨1Ħ1

E-mail: akiyamak@md.tsukuba.ac.jp; Tel: 029-853-3330
E-mail: yabek@md.tsukuba.ac.jp; Tel: 029-853-3231
3E-mail: dsutoo@md.tsukuba.ac.jp; Tel: 029-853-3113
28

(1)Wistar [HK2ŕŁÈĩ"ĥy .\`łĠİĈćőªë(PBS, 100 ml) 2ñōĥy.Ĺ"Į÷2ĦĮ(2) ĞÖ ĵĲ¤²÷ (4ŖP[V]X4]JQL 0.2Ŗ=]F]4]JQL2) PBS þ÷, 250 ml) 2āóĹ2¤²(3) ħ2/Ě 5 mm "T_H<!4"¤²÷j 5 ÙņÅ¤²
(4) ħT_H<2 PBS  1 Ùņ (15 4 ¢)òôÅ5Ŗ?Zę2) PBS þ÷! 4 12 Ùņöÿ"Ôu# ĜÔuÙ!ěġ!ì
ĎĈěġ Ó{0"2Ň+"0(5)ĜæÝĉ"¨!ħ2¨L[646Ag
 Ĝ(6) <\8AFHK 20 µm "!Ĭ
D[G`a<_XØēþ÷>bI5`=A[6L:[A!ķ/oD[G`">bI
5`=#Êj!A[6L:[A . #10"2ŇÄ2ÐÝ³œ#ģ°ğ .
y%Ě 8.0 mm (£ 1 A) $Ě 5.1 mm (£ 1 B) "2ĉ

2 ¢"ĭ~ÃÀx"º . CaM "JbF Æ.1
1."JbF2>`RYbFb!-Ċ|c"ă "»"Ľ2ãĳ"×ï#2AIb@"rĢ!èĒ
!ŀĢ0É 0"ÎïA[6L:[A"!f"Wb<2oÛ"û~"ŋ!1."Wb<"Áæx2û²ç!2 ¢pň"û~AIb@"ÇıĢ2ĵĘWb<2èĒ!Áæ!CHK"Ôu!-0ŀĢ"Ĵº#1 µm Üüû~Þq#ph"Ļ/0ĸðń 420-490nm¾ùS5]Fb 530 nm~Ō¯«wė"Ō¥ 850 V·ă^`B 20ŗ0.75 (wĆŗŅÕ)
Ńĝ/ 20 µmû~ĝ/ 100 µmû~ņŊ 20 µm
û~ARbL100 Ő©ŗĕ÷ 100 µm "1mM đł;MbN .Ď.10ĭ~ÃÀ2 100 ·ď ĭ~ÃÀx2í*

2.2 čěġ±àĪ3.1 ă"»£ 2 ![HKħ"Ő©! 0 THCaMKIIc2THCaMKII $ CaM "Ït2ĉ
$ CaM "»£2Ĕ£ 3 !#1."
6EG8?4`łS]8^C6` (FITC) æĶ" 2 Ïtï!-0ĭ~čěġ±àĪ2į»2êĺ£2Ĕ.!£ 4 !#ă "Ït"ĀÀ#kz³œ .î²čěġ³ŋ"ĭ~ÃÀx2ĔTHCaMKII $ CaM±àĪ"ÔuÎŏ2ph!Ĕ#ħ"'3"Ő© µ1 "(1) A[6L:[A!ķ/o2 PBS ò»#ă !-/Č 
ô¨2}!/ŉ(2) æýĮø2
TH "»Ř ğÞt ¿hĿ¡ĜĘy§á!"
4 2 ÙņÊÅPBS òô!Ŕ^U]»ğÞt"yŐ©#
(3) æďă !·0Ït (Ė 1 Ït) 2!"Ĥ¬y.Ĩy%
ĀÀŀµ1Ĥ4 12 ÙņÊÅ PBS òôÜÊ"¬yĿ#ĨyĿ!ê&Ě70%Ŕ^U]Ït2ŉ(4) FITC æĶĖ 2 Ït2
CaMKII "»Ř TH , CaM !ê&Ő©!!"ľ~h"´ú 3 ÙņÊ(5) ľ~h0^U]"º­õŒ­ħĐ ğÞÕÙņPBS 2mÒ.d¶!òôÜty§á¡ĜĘ¬yjŊáÍâ!Ŕ^U]
Ê"Ït g!é0ßx!Ĵº Ĉ0"» (.1õŒ"^U] Û+Ŕ *}!òô0É 0(6) 10%=\C\` PBS þ÷¸!ßæÝ"vė# ¿hĿ#sj^U]ğÞt yŐ©
#Ĥy$ĨyĿ"^U] j®Ŀ!ê&Ě4"ÚÌį
35%Ŕ Û! TH "Ït2àĪĭ~ÃÀ2û²CaM "»Ř n"lă !ê&êĺď¦c!
ç!PBS jd¶!9Ob:[A2#»­ħĐ  ¿hĿ¡ĜĘõ
CaMKII !·0ÏtàĪæÝ2Áæ!
Œy§áğÞt!#Ŕ^U]»
CHKû²å!2 CaM !·ğÞt yŐ©#Ĥ¬yĿ,ĨyĿ"^U]0ÏtàĪcÁæhû²2 ċpj®Ŀ-/+Ŕ ň"àĪÔu#ľ~hį
ă "ĭ~ÃÀ"ßÅ2MHA]àĪ
Ë#4CG]>\`7AI[bDàĪħ4K
3.2 fă "»"êĺ[A2ĂĿr2²THCaMCaMKII #ğÞty§á$¡ĜĘ! !Ŕ^U]»ğÞt
2.3 »ß#Ą! yĤ¬yĿ¹yĿ"Ő©! "ăä*Ŕ^U]2ĔļĐ !
ĭ~čěġ±àĪħ"Ő©2+fă
#êĺďŔ^U]Brain Mapping Analyzer !-20 µm ņŊĚ 25
¿hĿ#TH CaM ^U] Ŏ½!Ŕ e31 eŐ©!û~Û!àĪĄ!Âąá#ÃàĪ1CaMKII ^U]ă(TH) "JbF#àĪÅ"û² .ÑÆ.
#s

õŒ"
CaMKII^U]#īŔ 12 ċpň!àĪă(CaMKII  CaM)TH
CaM#jŔ^U]CaMKII^U]"JbF#ă "àĪÅ"ĭ~ÃÀx"º#¬yjŊáŔ·¼sTH.Æ.1Ő©" 2 ¢ 1 ¢"ĭ~CaM#iŐ©+j^U]ÃÀx"º . CaMKII "JbF Æ.13 ¢

90 2. /$IK=97

3

CGJ,2A3PE*40&O;ML+(DIK,2=9Brain Mapping Analyzer TH (A, D)
CaMKII (B, E) - CaM (C, F) *43PE#8) A-C 0 1A T1D-F 0 1B T1
+*:   L+ 20 µm QS ?'H 25 %T1 (A-C) -H 31 %T1 (D-F) .A@5*4<) 7 # 8 >R"!*U #NF (Brain Res. 933 (2002) 1–11 6B)

10

3 3. 2%LOB>)=KM-5GDU?
3 2 J
THCaMKII / CaM  $HGV*8DU?R
A-C /
 E-G 3 1A Z4D / H 3 1B Z4+?
N@
A-D: 2 G*82%:B&DU
0GQ(<9Y.\FE 8 CX*, L1
64 PSJ A / D: TH (Y)  CaMKII (\)B: TH (Y)  CaM (\)C: CaMKII (Y)  CaM (\) *8W'DU E-H: 2%:B& 2 GVF976ITYFE0 8 CXSJE/ H: TH D CaMKII #!"[Z4TJ CaMKII D TH #!"[Z4YJ 2ACaM (T)  TH (Y) *87 F CaM (T)  CaMKII (Y) *87
G J (Brain Res. 933 (2002) 1–11 ;H)11

s 4. nÕëw) THCaMKII k! CaM _·ÌÑi¼Ø^W

Då_·ÌÑi¢×>35Õd ' Brain Mapping Analyzer &n² ±+b10 j>35 'pCëwd+** 2 ¡ (o 20 ¡) â,c nëw(Ê 1000-3000 V4B2+é#uW§°XW+«#nëw4B2 §°²) 1 mM ¿ä/7B8Ø^+ 100  ¼Ø^WÁ)
(Brain Res. 933 (2002) 1-11 &(´)ÂÍOá²Õa¦y+O[ +ÛÇ)åf+)ÕnãP¨Ô+½)# 6B9;A+}#)ÂÍOá² c+ Ë æ¼c )
 Gm©)Ã` c ­ÚÒç»+ÙÄ² c+ËÓ@:?æµ\i)Brain Mapping Analyzer +[1, 2]
ÚÒ taz|Æ¦¾ÅS´*)
ÚÒ+´í+å³®+Þl*.?0-< Õa CaM U~É+®i TH + ®i Î ÏQ%Yv£6B9;AoÔ+Kà)I+M]ì 
[7-9]xÀ¼=.71<+xÕa6B9;ARhÉ¶ Áq*) ¸¹12+c »º¨%Hè­¬­+ç»)#xÀ¼4B2+T  [5, 6,10-17]Õ¥ß¨Ô ¤#ê $Ð)#ãP Z *) ¨Ô ¶)Õ¦¨Ô%ÂÍi² JR´+ )# pCÌÑdE² c+æ) Gm©)*"pCdEn² +**¶)Ø^²§Ü¼)­  *'+æ)Ö­  LrBrain
Mapping Analyzer +´{å_·ÌÑi¢×epCNFØ^+¯È+«#)&(² c+æ¼ªÝ )g[3, 4]

h(jÁX (FITC) É
%jFaËÖ{:*A1E(U¢%  (jFNIX%
"$ªy(}%  % #
9D=EA(Î¦%~wÝn (vhÝnvØ 0.01 ¯¨aËX"%ÁXÍ¾) rÓXÚ[ à4E1}#&uß·RWmTHCaM e CaMKII YàB<A\z¶(o¶[5-9]i'º% &#Ýn %6E8>DiCaM e CaMKII (K,A.+?"È² &% «k &%l¶²Ïc§ GÌ¦àB<A\z$ &#ÝnCaM ³(K TH d &%g»«k &%F|IÒTH  CaM àB<A\zCaMKII B<AÌ¦Q  #|IÒ % TH dCaMKII Mq;C3*D-7E0"JÈ² &%g»º#&%

Brain Mapping Analyzer (¢jF´¸]H\z%ds\z(tÔÙ¦
%(×¥FV@25¼Z THCaMKII e CaM (·RWm
GYàB<A\z% (ªÇ &#Ýn,A.+?
CaM ³(K TH (d6E8>DB<A(p_ % «k &%j´¸ZdsÙS¢( %¼»!¬µ¤±(©°%Hb%º%

©°sÃ½O®s©°ÊÅ`Õ(12922044, 13922045, 13922047, 14922050, 15922046,17927001, 17928009 e 18927001)  `(f Â13
[1] ÜÀP, ­xTL, ^£FÑ, ¼Z¬µPÐ\z\Þ~XÄ¹./3?×¥, ¿¡sÛÆ 91 (1988) 173-180.
[2] D. Sutoo, K. Akiyama, K. Yabe, Quantitative mapping
analyzer for determining the distribution of neurochemicals
in the human brain, J. Neurosci. Methods 85 (1998)
161-173.
[3] D. Sutoo, K. Akiyama, K. Yabe, Comparison analysis ofdistributions of tyrosine hydroxylase, calmodulin andcalcium/calmodulin-dependent protein kinase II in a triple
stained slice of rat brain, Brain Res. 933 (2002) 1-11.
[4] D. Sutoo, K. Akiyama, K. Yabe, A novel technique forquantitative immunohistochemical imaging of various
neurochemicals in a multiple-stained brain slice, J.
Neurosci. Methods 118 (2002) 41-50.
[5] D. Sutoo, K. Akiyama, Regulation of blood pressure withcalcium-dependent dopamine synthesizing system in thebrain and its related phenomena, Brain Res. Rev. 25 (1997)
1-26.
[6] D. Sutoo, K. Akiyama, Regulation of brain function byexercise, Neurobiol. Dis. 13 (2003) 1-14.
[7] D. Sutoo, K. Akiyama, M. Geffard, Central dopaminesynthesis regulation by the calcium-calmodulin-dependent
system, Brain Res. Bull. 22 (1989) 565-569.
[8] D. Sutoo, K. Akiyama, K. Yabe, K. Kohno, Multiple
analysis of tyrosine hydroxylase and calmodulin distributions in the forebrain of the rat using a microphotometry
system, Brain Res. Bull. 26 (1991) 973-982.
[9] D. Sutoo, K. Akiyama, K. Yabe, Quantitative imaging oftyrosine hydroxylase and calmodulin in the human brain, J.
Neurosci. Res. 63 (2001) 369-376.
[10] K. Akiyama, D. Sutoo, Rectifying effect of exercise onhypertension in spontaneously hypertensive rats via a
calcium-dependent dopamine synthesizing system in thebrain, Brain Res. 823 (1999) 154-160.
[11] D. Sutoo, K. Akiyama, Effect of cadmium or magnesium
on calcium-dependent central function that reduces bloodpressure, Arch. Toxicol. 74 (2000) 1-4.
[12] K. Akiyama, D. Sutoo, The mechanism by which exercise
reduces blood pressure, In: Frontiers of the Mechanisms ofMemory and Dementia, T. Kato (Ed.), Elsevier,
Amsterdam (2000) 109-110.
[13] D. Sutoo, K. Akiyama, Opposite effects of calcium andmagnesium on the central blood pressure regulation in the
spontaneously hypertensive rats, Jpn. J. Pharmacol. 86(2001) 366-368.
[14] D. Sutoo, K. Akiyama, Neurochemical changes in micefollowing physical or psychological stress exposures,
Behav. Brain Res. 134 (2002) 347-354.
[15] D. Sutoo, K. Akiyama, The significance of increase instriatal D 2 receptors in epileptic EL mice, Brain Res. 980(2003) 24-30.
[16] D. Sutoo, K. Akiyama, Music improves dopaminergic
neurotransmission: demonstration based on the effect ofmusic on blood pressure regulation, Brain Res. 1016
(2004) 255-262.
[17] D. Sutoo, K. Akiyama, Daily exercise and stress on brain
function, In: Trends in Exercise and Health Research, R. L.
Swan (Ed.), Nova Science, New York (2005) 23-48.